Advertisement

Dementias pp 77-101 | Cite as

Alzheimer’s Disease

  • A. Bianchetti
  • M. Trabucchi

Abstract

Alzheimer’s disease (AD) is the most common of the dementing disorders. Once considered a rare disorder, AD is now recognized as a major cause of death and a growing public health problem. In 1907, Alois Alzheimer reported the first case of the illness that bears his name, a 51-year-old woman with progressive cognitive decline and behavioral changes associated with distinctive neuropathological features [1]. Much time has passed since then, however. Until recently, there has been widespread nihilism in the clinical approach to the demented patient. Most physicians believed that there was little reason to spend money or effort diagnosing diseases with no known risk factors, preventive measures or treatments [2]. However, a multidisciplinary effort has transformed this field, leading to a better understanding of the clinical presentation, risk factors, pathogenesis and treatment of the other degenerative dementias [3].

Keywords

Alzheimer Disease Amyloid Precursor Protein Behavioral Disturbance Lewy Body Dementia Paired Helical fIlaments 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Maurer K, Volk S, Gerbaldo H, Auguste D (1997) Alzheimer’s disease. Lancet 349: 1546–1549PubMedCrossRefGoogle Scholar
  2. 2.
    Small GW, Rabins PV, Barry PP, Buckholtz NS, DeKosky ST, Ferris SH, Finkel SI, et al (1997) Diagnosis and treatment of Alzheimer disease and related disorders. Consensus Statement of the American Association for Geriatric Psychiatry, the Alzheimer’s Association, and the American Geriatrics Society. JAMA 278: 1363–1371PubMedCrossRefGoogle Scholar
  3. 3.
    Miller B (1997) Clinical advances in degenerative dementias. Br J Psychiatry 171: 1–3PubMedCrossRefGoogle Scholar
  4. 4.
    Hofrnan A, Rocca WA, Brayne C, Breteler MM, Clarke M, Cooper B, Copeland JR, Dartigues JF, da Silva Droux A, Hagnell O (1991) The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol 20: 736–748CrossRefGoogle Scholar
  5. 5.
    Hebert LE, Scherr PA, Beckett LA, Albert MS, Pilgrim DM, Chown MJ, Funkenstein HH, Evans DA (1995) Age specific incidence of Alzheimer’s disease in a community population. JAMA 273: 1354–1359PubMedCrossRefGoogle Scholar
  6. 6.
    Drachman DA (1994) If we live long enough, will we all be demented? Neurology 44: 1563–1565PubMedCrossRefGoogle Scholar
  7. 7.
    Ritchie K, Kildea D (1995) Is senile dementia “age-related” or “ageing-related”? — evidence from meta-analysis of dementia prevalence in the oldest old. Lancet 346: 931–934PubMedCrossRefGoogle Scholar
  8. 8.
    Larrabee GJ, McEntee WJ (1995) Age-associated memory impairment: sorting out the controversies. Neurology 45: 611–614PubMedCrossRefGoogle Scholar
  9. 9.
    Christensen H, Henderson AS, Jorm AF, Mackinnon AJ, Scott R, Korten AE (1995) ICD-10 mild cognitive disorder: epidemiological evidence on its validity. Psychol Med 25: 105–120PubMedCrossRefGoogle Scholar
  10. 10.
    Hanninen T, Hallikainen M, Koivisto K, Helkala EL, Reinikainen KJ, Soininen H, Mykkanen L, Laakso M, Pyorala K, Riekkinen PJ Sr (1995) A follow-up study of ageassociated memory impairment: neuropsychological predictors of dementia. J Am Geriatr Soc 43: 1007–1015PubMedGoogle Scholar
  11. 11.
    Fratiglioni L (1993) Epidemiology of Alzheimer’s disease. Issues of etiology and validity. Acta Neurol Scand 145: 1–70Google Scholar
  12. 12.
    St.George-Hyslop P, Tanzi RE, Polinsky RJ (1987) The genetic defect causing familial Alzheimer’s disease maps on chromosome 21. Science 235: 885–889PubMedCrossRefGoogle Scholar
  13. 13.
    Goate A, Chartier-Harlin MC, Mullan M (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer’s disease. Nature 349: 704–706PubMedCrossRefGoogle Scholar
  14. 14.
    Sorbi S (1993) Mulecular genetics of Alzheimer’s disease. Aging Clin Exp Res 5: 417–425Google Scholar
  15. 15.
    Mullan M, Crawford F, Buchanan J (1994) Technical feasibility of a genetic testing for Alzheimer’s disease. Alzheimer Dis Assoc Disord 8: 102–115PubMedCrossRefGoogle Scholar
  16. 16.
    Schellenberg G, Bird T, Wijsman E, et al (1992) Genetic linkage evidence for a familial Alzheimer’s disease locus on chromosome 14. Science 258: 668–671PubMedCrossRefGoogle Scholar
  17. 17.
    Sherrington R, Rogaev El, Liang Y, et al (1995) Cloning a gene bearing a missense mutations in early-onset familial Alzheimer’s disease. Nature 375: 754–760PubMedCrossRefGoogle Scholar
  18. 18.
    Lendon CL, Ashall F, Goate AM (1997) Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 277: 825–831PubMedCrossRefGoogle Scholar
  19. 19.
    Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W (1996) The presenilin genes and their role in early-onset familial Alzheimer’s disease. Alzheimer Dis Rev 1: 91–98Google Scholar
  20. 20.
    Levy-Lahad E, Wijsman EM, Nemens E, et al (1995) A familial Alzheimer’s disease locus on chromosome 1. Science 269: 970–973PubMedCrossRefGoogle Scholar
  21. 21.
    Frisoni GB, Trabucchi M (1997) Clinical rationale of genetic testing in dementia. J Neurol Neurosurg Psychiatry 62: 217–221PubMedCrossRefGoogle Scholar
  22. 22.
    Hardy J (1996) New insights into the genetics of Alzheimer’s disease. Ann Med 28: 255–258PubMedCrossRefGoogle Scholar
  23. 23.
    Dickson DW, Liu WK, Yen SH (1996) An antibody to an amino-terminal domain of presenilin-1 immunostains neurofibrillary tangles in Alzheimer’s disease. Neurobiol Aging 17: S18CrossRefGoogle Scholar
  24. 24.
    Farrer LA (1997) Genetics and the dementia patient. Neurologist 3: 13–30CrossRefGoogle Scholar
  25. 25.
    Strittmatter WJ, Saunders AM, Schmechel D, et al (1993) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977–1981PubMedCrossRefGoogle Scholar
  26. 26.
    Saunders AM, Strittmatter WJ, Schmechel D, et al (1993) Association of apolipoprotein E allele epsilon 4 with late onset familial and sporadic Alzheimer’s disease. Neurology 43: 1467–1472PubMedCrossRefGoogle Scholar
  27. 27.
    Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Pitas RE (1994) Differential effects of apolipoprotein ε3 and ε4 on neuronal grow in vitro. Science 264: 850–852PubMedCrossRefGoogle Scholar
  28. 28.
    Frisoni GB, Calabresi L, Geroldi C, Bianchetti A, D’Acquarica AL, Trabucchi M, Govoni S, Franceschini G (1994) Apolipoprotein E e4 allele in Alzheimer’s disease and vascular dementia. Dementia 5: 240–242PubMedGoogle Scholar
  29. 29.
    Corder EH, Saunders AM, Strittmatter WJ, et al (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261: 921–923PubMedCrossRefGoogle Scholar
  30. 30.
    Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer’s disease. A meta-analysis. JAMA 278: 1349–1356PubMedCrossRefGoogle Scholar
  31. 31.
    Evans DA, Beckett LA, Field TS, Feng L, Albert MS, et al (1997) Apolipoprotein E ε4 and incidence of Alzheimer disease in a community population of older persons. JAMA 277: 822–824PubMedCrossRefGoogle Scholar
  32. 32.
    Slooter AJC, Tang MX, Dujin CM, Stern Y, Ott A, et al (1997) Apolipoprotein E ε4 and the risk of dementia after stroke. JAMA 277: 818–821PubMedCrossRefGoogle Scholar
  33. 33.
    Nicol JAR, Roberts GW, Graham DJ (1995) Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury. Nat Med 1: 135–137CrossRefGoogle Scholar
  34. 34.
    Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, et al (1997) Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 278: 1237–1241PubMedCrossRefGoogle Scholar
  35. 35.
    Stephenson J (1997) Reserchers find evidence of a new gene for late-onset Alzheimer disease. JAMA 277: 775PubMedCrossRefGoogle Scholar
  36. 36.
    Mortimer JA, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, Jorm AF, Kokmen E, Kondo K, Rocca WA, et al (1991) Head trauma as a risk factor for Alzheimer’s disease: a collaborative re-analysis of case-control studies. EURODEM risk factors research group. Int J Epidemiol 20[Suppl 2]: S28–S35PubMedCrossRefGoogle Scholar
  37. 37.
    Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R (1994) Influence of education and occupation on the incidence of Alzheimer’s disease. JAMA 271: 1004–1010PubMedCrossRefGoogle Scholar
  38. 38.
    Rocca WA (1994) Frequency, distribution, and risk factors for Alzheimer’s disease. Nurs Clin North Am 29: 101–111PubMedGoogle Scholar
  39. 39.
    Breteler MM, van Dijon CM, Chandler V, Fratiglioni L, Graves AB, He-man A, Corm AF, Kokune E, Kondo K, Mortimer JA, et al (1991) Medical history and the risk of Alzheimer’s disease: a collaborative re-analysis of case control study. EURODEM risk factors research group. Int J Epidemiol 20[Suppl 2]: S36–S42PubMedCrossRefGoogle Scholar
  40. 40.
    Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277: 813–817PubMedCrossRefGoogle Scholar
  41. 41.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–944PubMedCrossRefGoogle Scholar
  42. 42.
    Terry RD, Masliah E, Hansen LA (1994) Structural basis of the cognitive alterations in Alzheimer disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven, New York, pp 179–196Google Scholar
  43. 43.
    Goedert M (1993) Tau protein and the neurofibrillary pathology of Alzheimer’s disease. Trends Neurosci 16: 460–465PubMedCrossRefGoogle Scholar
  44. 44.
    Goedert M, Jakes R, Spillantini MG, Crowther RA (1994) Tau protein and Alzheimer’s disease. In: Hyams JS, Lloyd CW (eds) Microtubules, modern cell biology, vol 13. Wiley-Liss, New York, pp 183–200Google Scholar
  45. 45.
    Lee VMY, Balin BJ, Otvos L Jr, Trojanowski JQ (1991) A 68: a major subunit of paired helical filaments and derivatized form of normal tau. Science 251: 675–678PubMedCrossRefGoogle Scholar
  46. 46.
    Esiri MM, Pearson RCA, Steele JE, Bowen DM, Powell TPS (1990) A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 53: 161–165PubMedCrossRefGoogle Scholar
  47. 47.
    Mann DMA (1989) The pathogenesis and progression of the pathological changes of Alzheimer’s disease. In: Davies DC (ed) Current problems in neurology. II. Alzheimer’s disease: towards an understanding of the aetiology and pathogenesis. John Libbey, London, pp 43–53Google Scholar
  48. 48.
    Zemlan FP, Vogelsong GD, McLaughlin L, Dean GE (1994) Alzheimer’s paired helical filaments: amyloid precursor protein epitope mapping. Brain Res Bull 33: 387–392PubMedCrossRefGoogle Scholar
  49. 49.
    Robakis NK (1994) Beta amyloid and amyloid precursor protein chemistry, molecular biology and neuropathology in Alzheimer disease. In: Terry RD, Katzman R, Bick KL (1994) Alzheimer disease. Raven, New York, pp 317–325Google Scholar
  50. 50.
    Blennow K, Cowburn RF (1996) The neurochemistry of Alzheimer’s disease. Acta Neurol Scand Suppl 168: 77–86PubMedCrossRefGoogle Scholar
  51. 51.
    Aisen PS, Davis KL (1994) Inflammatory mechanism in Alzheimer’s disease: implications for therapy. Am J Psychiatry 151: 1105–1113PubMedGoogle Scholar
  52. 52.
    Mirra SS, Gearing M, Nash F (1997) Neuropathologic assessment of Alzheimer’s disease. Neurology 49[3 Suppl]: S14–S16PubMedCrossRefGoogle Scholar
  53. 53.
    Drachman DA, Leavitt J (1974) Human memory and the cholinergic system: a relationship to aging? Arch Neurol 30: 113–121PubMedCrossRefGoogle Scholar
  54. 54.
    Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1297–1299CrossRefGoogle Scholar
  55. 55.
    Geula C, Mesulam MM (1989) Cortical cholinergic fibers in aging and Alzheimer’s disease: a morphometric study. Neuroscience 33: 469–481PubMedCrossRefGoogle Scholar
  56. 56.
    Rossor M, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL (1982) A postmortem study of the cholinergic and GABA systems in senile dementia. Brain 105: 313–330PubMedCrossRefGoogle Scholar
  57. 57.
    Pilleri G (1966) The Kluver Bucy syndrome in man — a clinicoanatomical contribution to the function of the medial temporal lobe structures. Psychiatr Neurol 152: 65CrossRefGoogle Scholar
  58. 58.
    Nitsch RM (1996) From acetylcholine to amyloid: neurotransmitters and the pathology of Alzheimer’s disease. Neurodegeneration 5: 477–482PubMedCrossRefGoogle Scholar
  59. 59.
    Palmer AM (1996) Neurochemical studies of Alzheimer’s disease. Neurodegeneration 5: 381–391PubMedCrossRefGoogle Scholar
  60. 60.
    Palmer AM, Gershon S (1990) Is neuronal basis of Alzheimer’s disease cholinergic or glutamatergic. FASEB J 4: 2745–2752PubMedGoogle Scholar
  61. 61.
    Geldmacher DS, Whitehouse PJ (1996) Evaluation of dementia. N Engl J Med 335: 330–336PubMedCrossRefGoogle Scholar
  62. 62.
    Rossor M (1993) Alzheimer’s disease. BMJ 307: 779–782PubMedCrossRefGoogle Scholar
  63. 63.
    Bianchetti A, Rozzini R, Trabucchi M (1994) Demenze. In: De Leo D, Stella A (eds) Manuale di psichiatria dell’anziano. Piccin, Padova, pp 343–371Google Scholar
  64. 64.
    Binetti G, Bianchetti A, Padovani A, Lenzi G, De Leo D, Trabucchi M (1993) Delusions in Alzheimer’s disease and multi-infarct dementia. Acta Neurol Scand 88: 5–9PubMedCrossRefGoogle Scholar
  65. 65.
    Cummings JL (1997) Changes in neuropsychiatric symptoms as outcome measures in clinical trials with cholinergic therapies for Alzheimer disease. Alzheimer Dis Assoc Disord 11[Suppl 4]:S1–S9PubMedGoogle Scholar
  66. 66.
    Trabucchi M, Bianchetti A (1996) Delusions. Int Psychogeriatr 8[Suppl 3]: 383–386PubMedGoogle Scholar
  67. 67.
    Bianchetti A, Scuratti A, Zanetti O, Binetti G, Frisoni GB, Magni E, Trabucchi M (1995) Predictors of mortality and institutionalization in Alzheimer’s Disease patients one year after discharge from an Alzheimer’s dementia Unit. Dementia 6: 108–112PubMedGoogle Scholar
  68. 68.
    American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington DCGoogle Scholar
  69. 69.
    Zanetti O, Bianchetti A, Frisoni GB, Rozzini R, Trabucchi M (1993) Determinants of disability in Alzheimer’s disease. Int J Geriatr Psychiatry 8: 581–586CrossRefGoogle Scholar
  70. 70.
    Gearing M, Mirra SS, Hedreen JC, Sumi SH, Hansen LA, Heyman A (1995) CERAD part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology 45: 461–466PubMedCrossRefGoogle Scholar
  71. 71.
    Rasmusson DX, Brandt J, Steele C, Hedreen JC, Troncoso JC, Folstein MF (1996) Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology. Alzheimer Dis Assoc Dis 10: 180–188CrossRefGoogle Scholar
  72. 72.
    Teri L, McCurry SM, Edland SD, Kukull WA, Larson EB (1995) Cognitive decline in Alzheimer’s disease: a longitudinal investigation of risk factor for accelerated decline. J Gerontol 50A: M49–M55CrossRefGoogle Scholar
  73. 73.
    Strauss ME, Lee MM, Di Filippo JM (1997) Premorbid personality and behavior symptoms in Alzheimer disease. Arch Neurol 54: 257–259PubMedCrossRefGoogle Scholar
  74. 74.
    Kitwood T (1993) Person and process in dementia. Int J Geriatr Psychiatry 8: 541–545CrossRefGoogle Scholar
  75. 75.
    Corey-Bloom J, Thal LJ, Galasko D, Folstein M, Drachman D, Raskind M, Lanska DJ (1995) Diagnosis and evaluation of dementia. Neurology 45: 211–218PubMedCrossRefGoogle Scholar
  76. 76.
    Geroldi C, Frisoni GB, Bianchetti A, Trabucchi M (1997) Drug treatment in Lewy body dementia. Dement Geriatr Cogn Disord 8: 188–197PubMedCrossRefGoogle Scholar
  77. 77.
    Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198PubMedCrossRefGoogle Scholar
  78. 78.
    Blessed G, Tomlinson BE, Roth M (1968) The association between quantitative measures of dementia and of senile change in the cerebral gray matter of elderly subjects. Br J Psychiatry 114: 797–811PubMedCrossRefGoogle Scholar
  79. 79.
    Cipolotti L, Warrington EK (1995) Neuropsychological assessment. J Neurol Neurosurg Psychiatry 58: 655–664PubMedCrossRefGoogle Scholar
  80. 80.
    Frisoni GB, Rozzini R, Bianchetti A, Trabucchi M (1993) Principal lifetime occupation and MMSE score in the community dwelling elderly. J Gerontol Soc Sci 48: 310–314Google Scholar
  81. 81.
    Cronin-Golomb A, Corkin S, Rosen TJ (1993) Neuropsychological assessment of dementia. In: Whitehouse PJ (ed) Dementia, vol 40 (Contemporary Neurology Series). Davis, Philadelphia, pp 130–164Google Scholar
  82. 82.
    Magni E, Binetti G, Bianchetti A, Rozzini R, Trabucchi M (1996) Mini-Mental State Examination: a normative study in italian ederly population. Eur J Neurol 3: 1–5CrossRefGoogle Scholar
  83. 83.
    Reuben DB (1993) Use and abuse of assesement instruments. In: Osterwail D, Reuben DB, Rozzini R, Rubenstein LZ, Trabucchi M (eds) New frontiers in geriatric medicine. Kendall, Padova, pp 17–26Google Scholar
  84. 84.
    Reuben DB, Solomon DH (1989) Assessement in geriatrics: of caveats and names. J Am Geriatr Soc 37: 570–572PubMedGoogle Scholar
  85. 85.
    Zanetti O, Bianchetti A, Trabucchi M (1995) The puzzle of functional status in mild and moderate Alzheimer’s disease: self-report, family report, and performance-based assessement. Gerontologist 35: 148PubMedCrossRefGoogle Scholar
  86. 86.
    Guralnik JM, Branch LG, Cummings SR, Crib JD (1989) Physical performance measures in aging research. J Gerontol 44: 141–146CrossRefGoogle Scholar
  87. 87.
    NIH Consensus Conference (1987) Differential diagnosis of dementing diseases. JAMA 23: 3411–3416Google Scholar
  88. 88.
    Clarfield AM (1988) The reversible dementia: do they reverse? Ann Int Med 109: 476–486PubMedGoogle Scholar
  89. 89.
    Weytingh MD, Bossuyt PMM, van Crevel H (1995) Reversible dementia: more than 10% or less than 1%? A quantitative review. J Neurol 242: 446–471Google Scholar
  90. 90.
    Chui H, Zhang Q (1997) Evaluation of dementia: a systematic study of the American Academy of Neurology Practice Parameters. Neurology 49: 925–935PubMedCrossRefGoogle Scholar
  91. 91.
    Growdon JH (1995) Advances in the diagnosis of Alzheimer’s disease. In: Iqbal K, Mortimer JA, Winblad B, Wisniewski HM (eds) Recent advances in Alzheimer’s disease and related disorders. Wiley, Chichester, pp 139–154Google Scholar
  92. 92.
    Gasparini L, Racchi M, Binetti G, Trabucchi M, Solerte B, Alkon D, Etcheberrigaray R, Gibson G, Blass J, Paoletti R, Govoni S (1998) Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer’s disease. FASEB J 12: 17–34PubMedGoogle Scholar
  93. 93.
    Geldmacher DS, Whitehouse PJ (1997) Differential diagnosis of Alzheimer’s disease. Neurology 48[Suppl 6]: S2–S9PubMedCrossRefGoogle Scholar
  94. 94.
    Green RC, Clarke VC, Thompson NJ, Woodard JL, Letz R (1997) Early detection of Alzheimer disease: methods, markers, and misgivings. Alzheimer Dis Assoc Disord 11[Suppl 5]:S1–S5PubMedGoogle Scholar
  95. 95.
    Post SG (1994) Genetics, ethics, and Alzheimer disease. J Am Geriatr Soc 42: 782–786PubMedGoogle Scholar
  96. 96.
    Post SG, Whitehouse PJ, Bisntock RH, Bird TD, Eckert SK, et al (1997) The clinical introduction of genetic testing for Alzheimer disease: an ethical perspective. JAMA 277: 832–836PubMedCrossRefGoogle Scholar
  97. 97.
    Frisoni GB, Bianchetti A, Trabucchi M, Govoni S (1996) Diagnostic usefulness of apolipoprotein E ε4 in the diagnosis of dementia. J Neurol Neurosurg Psychiatry 60: 699–700PubMedCrossRefGoogle Scholar
  98. 98.
    Relkin NR (1996) National Institute on Aging/Alzheimer’s Association Working Group. Apolipoprotein E genotyping in Alzheimer’s disease. Lancet 347: 1091–1095Google Scholar
  99. 99.
    Jagus WJ, Eberling JL (1991) MRI, CT, SPECT, PET: their use in diagnosing dementia. Geriatrics 46: 28–35Google Scholar
  100. 100.
    Frisoni GB, Bianchetti A, Geroldi C, Trabucchi M, Beltramello A, Weiss C (1994) Measures of temporal lobe atrophy in probable Alzheimer’s disease. J Neurol Neurosurg Psychiatry 57: 1438–1439PubMedCrossRefGoogle Scholar
  101. 101.
    Frisoni GB, Pizzolato G, Govoni S, Bianchetti A, Ferlin G, Trabucchi M (1994) Single photon emission computed tomography with [99mTc]-HM-PAO and [123I]-IBZM in Alzheimer’s Disease and dementia of frontal type. Acta Neurol Scand 89: 199–203PubMedCrossRefGoogle Scholar
  102. 102.
    Rabins P, Blacker D, Bland W, Bright-Long L, Cohen E, Katz I, et al (1997) Practice guideline for treatment of patients with Alzheimer’s disease and other dementias of late life. Am J Psychiatry 154: 1–39Google Scholar
  103. 103.
    Lussignoli G, Frisoni GB, Bianchetti A, Trabucchi M (1998) Measurement of outcomes in Alzheimer’s disease. In: Vellas B, Fitten J, Frisoni GB (1998) Research and practice in Alzheimer’s disease. Serdi, Paris, pp 437–446Google Scholar
  104. 104.
    Kane RL (1995) Improving the quality of long-term care. JAMA 273: 1376–1380PubMedCrossRefGoogle Scholar
  105. 105.
    Brook RH, McGlynn EA, Cleary PD (1996) Maeasuring quality of care. N Engl J Med 335: 966–970PubMedCrossRefGoogle Scholar
  106. 106.
    Ramsay M, Winget C, Higginson I (1995) Review: measures to determine the outcome of community services for people with dementia. Age Aging 24: 73–83CrossRefGoogle Scholar
  107. 107.
    Zanetti O, Bianchetti A, Trabucchi M (1995) II geriatra e 1a gestione del paziente demente. Giorn Geront 43: 343–349Google Scholar
  108. 108.
    Bianchetti A, Zanetti O, Trabucchi M (1997) Non pharmacological treatment in Alzheimer’s disease. Funct Neurol 12: 215–217PubMedGoogle Scholar
  109. 109.
    Coons DH (1991) The therapeutic milieu: concepts and criteria. In: Coons DH (ed) Specialized dementia care units. John Hopkins University Press, BaltimoreGoogle Scholar
  110. 110.
    Rovner BW, Steel CD, Shumely Y, Folstein MF (1996) A randomized trial of dementia care in nursing home. J Am Geriatr Soc 44: 7–13PubMedGoogle Scholar
  111. 111.
    Burnside L, Haight B (1994) Reminiscence and life review: therapeutic interventions for older people. Nurs Pract 19: 55–61CrossRefGoogle Scholar
  112. 112.
    Feil N (1992) Validation: the Feil method. Feil, ClevelandGoogle Scholar
  113. 113.
    Bianchetti A, Benvenuti P, Ghisla KM, Frisoni GB, Trabucchi M (1997) An Italian model of Dementia Special Care Unit: results of a pilot study. Alzheimer Dis Assoc Disord 11: 53–56PubMedCrossRefGoogle Scholar
  114. 114.
    Zanetti O, Binetti G, Magni E, Rozzini L, Bianchetti A, Trabucchi M (1997) Procedural memory stimulation in Alzheimer’s disease: impact of a training programme. Acta Neurol Scand 95: 152–157PubMedCrossRefGoogle Scholar
  115. 115.
    Knopman DS, Morris JC (1997) An update on primary drug therapies for Alzheimer disease. Arch Neurol 54: 1406–1409PubMedCrossRefGoogle Scholar
  116. 116.
    Wilcock GK (1996) Current approach to the treatment of Alzheimer disease. Neurodegeneration 5: 505–509PubMedCrossRefGoogle Scholar
  117. 117.
    Summers WK, Majorski LV, Marsh GM, Tachiki K, Kling A (1986) Oral tetrahydroaminoacridine in long term treatment of senile dementia of Alzheimer type. N Engl J Med 315: 1241–1245PubMedCrossRefGoogle Scholar
  118. 118.
    Davis KL, Thal LJ, Gamzu ER, et al (1992) A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer’s disease. N Engl J Med 327: 1253–1259PubMedCrossRefGoogle Scholar
  119. 119.
    Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J (1992) A controlled trial of tacrine in Alzheimer’s disease. JAMA 268: 2523–2529PubMedCrossRefGoogle Scholar
  120. 120.
    Nightingale SL (1997) Donepezil approved for treatment of Alzheimer disease. JAMA 277: 10PubMedCrossRefGoogle Scholar
  121. 121.
    Geroldi C, Bianchetti A, Trabucchi (1997) Manipulation of the cholinergic system. Funct Neurol 12: 187–191PubMedGoogle Scholar
  122. 122.
    Lovestone S, Graham N, Howard R (1997) Guidelines on drug treatments for Alzheimer’s disease. Lancet 350: 232–233PubMedCrossRefGoogle Scholar
  123. 123.
    Levely A (1996) Muscarinic acetylcholine receptor expression in memory circuits. Implications for treatment of Alzheimer disease. PNAS 93: 13541–13546CrossRefGoogle Scholar
  124. 124.
    Skolnick AA (1997) Old Chinese herbal medicine used for fever yields possible new Alzheimer disease therapy. JAMA 277: 776–778PubMedCrossRefGoogle Scholar
  125. 125.
    Sano M, Ernesto C, Thomas RG, et al (1997) A controlled trial of Selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med 336: 1216–1222PubMedCrossRefGoogle Scholar
  126. 126.
    Riedel WJ, Jolies J (1996) Cognition enhancers in age-related cognitve decline. Drugs Aging 8: 245–274PubMedCrossRefGoogle Scholar
  127. 127.
    Aisen PS, Davis KL (1997) The search for disease-modifying treatment for Alzheimer’s disease. Neurology 48[Suppl 6]: S35–S41PubMedCrossRefGoogle Scholar
  128. 128.
    Teri L, Rabins P, Whitehouse PJ, Berg L, Reisberg B, Sunderland T, et al (1992) Management of behavior disturbane in Alzheimer disease: current knowledge and future directions. Alzheimer Dis Assoc Disord 6: 77–88PubMedCrossRefGoogle Scholar
  129. 129.
    Marchello V, Boczko F, Shelkey M (1995) Progressive dementia: strategies to manage new problems behaviors. Geriatrics 50: 40–43PubMedGoogle Scholar
  130. 130.
    Salzman C, Vaccaro B, Lieff J, Weiner AS (1995) Clozapine in older patients with psychosis and behavioral disturbances. Am J Geriatr Psychiatry 3: 26–33Google Scholar
  131. 131.
    Goldberg RJ, Goldberg J (1997) Risperidone for dementia-related disturbed behavior in nursing home residents: a clinical experience. Int Psychogeriatr 9: 65–68PubMedCrossRefGoogle Scholar
  132. 132.
    Tariot PN, Schenider LS, Katz IR (1995) Anticonvulsivant and other non-neuroleptic treatment of agitation in dementia. J Geriatr Psychiatry Neurol 8[Suppl 1]: S28–S39PubMedCrossRefGoogle Scholar
  133. 133.
    Teri L (1994) Behavioral treatment of depression in patients with dementia. Alzheimer Dis Assoc Disord 8[Suppl 3]: 66–74PubMedGoogle Scholar
  134. 134.
    Knesper DJ (1995) The depression in Alzheimer’s disease: sorting pharmacotherapy, and clinical advice. J Geriatr Psychiatry Neurol 8[Suppl 1]: S40–S51PubMedCrossRefGoogle Scholar
  135. 135.
    Dodds P (1994) Wandering: a short report on coping strategies adopted by informal careers. Int J Geriatr Psychiatry 9: 751–756CrossRefGoogle Scholar
  136. 136.
    Zanetti O, Magni E, Sandri C, Frisoni GB, Bianchetti A, Trabucchi M (1996) Determinants of burden in an Italian sample of Alzheimer’s patient caregivers. J Cross-Cultural Gerontol 11: 17–27Google Scholar
  137. 137.
    Burgeois MS, Shulz R, Burgio L (1996) Interventions for caregivers of patients with Alzheimer’s disease: a review and analysis of content, process, and outcomes. Int J Aging Hum Dev 43: 35–92CrossRefGoogle Scholar
  138. 138.
    Berg L, Buckwalter KC, Chafets PK, et al (1991) Special care units for persons with dementia. J Am Geriatr Soc 39: 1229–1236PubMedGoogle Scholar
  139. 139.
    Sloane PD, Lindeman DA, Phillips C, Moritz DJ, Koch G (1995) Evaluating Alzheimer’s special care units: reviewing the evidence and identifying potential sources of study bias. Gerontologist 35: 103–111PubMedCrossRefGoogle Scholar
  140. 140.
    Philpot MP, Levy R (1987) A memory clinic for the early diagnosis of dementia. Int J Ger Psychiatry 2: 195–200CrossRefGoogle Scholar
  141. 141.
    Trabucchi M, Bianchetti A, Zanetti O (1995) An italian network for the care of demented patients. Gerontologist 35[Suppl 1]: 90Google Scholar
  142. 142.
    Hughes CP, Berg L, Danziger WL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566–572PubMedCrossRefGoogle Scholar
  143. 143.
    Binetti G, Magni E, Rozzini L, Bianchetti A, Trabucchi M, Cummings JL (1995) “Neuropsychiatric Inventory”: validazione italiana di una scala per 1a valutazione psicopatologica della demenza. Giorn Geront 43: 864–865Google Scholar
  144. 144.
    Binetti G, Magni E, Cappa S, Padovani A, Bianchetti A, Trabucchi M (1993) Neuropsychological heterogeneity in mild Alzheimer’s disease. Dementia 4: 321–326PubMedGoogle Scholar
  145. 145.
    Cummings JL, Mega M, Gray K, Rosemberg-Thompson S, Carusi DA, Gornbei J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308–2314PubMedCrossRefGoogle Scholar
  146. 146.
    Migliorelli R, Teson A, Sabe L, et al (1995) Anosognosia in Alzheimer’s disease: a study of associated factors. J Neuropsychol Clin Neurosci 7: 338–344Google Scholar
  147. 147.
    Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel Index. Md Med J 14: 61–65Google Scholar
  148. 148.
    Lawton MP, Brody EM (1969) Assessement of older people; self-maintaining and instrumental activities of daily living. Gerontologist 9: 179–186PubMedCrossRefGoogle Scholar
  149. 149.
    Lowenstein DA, Amigo E, Duara R, Guterman A, Hurwitz D, Berkowitz N, Wilkie F, Weinberg G, Black B, Gittelman B, Eisdorfer C (1989) A new scale for the assessement of functional status in Alzheimer’s disease and related disorders. J Gerontol 44: 114–121CrossRefGoogle Scholar
  150. 150.
    Reuben DB, Siu AL (1990) An objective measure of physical function of elderly outpatients. J Am Geriatr Soc 38: 1105–1109PubMedGoogle Scholar
  151. 151.
    Volker L, Hurley AC, Lathi DC, Kowall NW (1994) Measurement of severity in advanced Alzheimer’s disease. J Gerontol 49: M223–M226CrossRefGoogle Scholar
  152. 152.
    Bellelli G, Frisoni GB, Bianchetti A, Trabucchi M (1997) The Bedford Alzheimer Nursing Severity Scale for the Demented: validation study. Alzheimer Dis Assoc Dis 11: 71–77CrossRefGoogle Scholar
  153. 153.
    Tinetti M (1986) Performance-oriented assessment of mobility problems in elderly patients. J Am Geriatr Soc 34: 119–126PubMedGoogle Scholar
  154. 154.
    De Leo D, Frisoni GB, Rozzini R, Bernardini M, Dello Buono M, Trabucchi M (1991) The Profile of Elderly Quality of Life (PEQOL): a quick package to assess general health conditions in old age. 5th Congress of the International Psychogeriatric Association, RomeGoogle Scholar
  155. 155.
    Greenfield S, Blanco DM, Elashoff RM, et al (1987) Development and testing of a new index of comorbidity. Clin Res 335–346Google Scholar
  156. 156.
    Heyman A, Wilkinson WE, Hurwitz BJ, Helms MJ, Haynes BA, Utley CM, Gwyther LP (1987) Early-onset Alzheimer’s disease: clinical predictors of institutionalization and death. Neurology 37: 980–984PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • A. Bianchetti
  • M. Trabucchi

There are no affiliations available

Personalised recommendations